Fapon Biotech Inc (http://en.faponbiotech.com/). was founded in 2001. Guided by the mission of "Enable Disease Identification Earlier, More Accurate, Convenient and Affordable", the company focuses on the future needs and trends of biotechnology developments and provides global diagnostic companies with high-performance IVD reagent raw materials, such as antigens, antibodies, and enzymes, as well as one-stop solutions with instrument and reagent services.
With the profound insight into the healthcare trend that shifts from diseasing treating to disease-preventing, Fapon Biotech had built a comprehensive technology platform. Over 1200 industrial-grade materials such as antibodies, antigens and enzymes were independently developed and launched, being widely applied in Rapid Test, ELISA, CLIA, CMIA, Biochemistry, Molecular Diagnosis, NGS, etc. One-stop solutions providing open instrument platforms and reagents were also introduced based on the in-depth understanding of industry trends to satisfy customers' needs in different application scenarios.
Fapon Biotech's products and services are highly integrated to promote synergic resources and shared values to the industry. Nowadays, the company has over 1000 partners around the world and is one of the very few Chinese IVD companies that have entered the high-end markets of developed countries in Europe, North America and Asia (Japan). Through continuous innovations in products and services, Fapon Biotech will make the developments of diagnostic technologies benefiting more people and advance the cause of human health.